Perioperative anaphylaxis: updates on pathophysiology

被引:1
|
作者
Jordan, Justin [1 ]
Levy, Jerrold H. [2 ,3 ,4 ]
Gonzalez-Estrada, Alexei [5 ]
机构
[1] TMC Hlth Med Educ Program, Tucson, AZ USA
[2] Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC USA
[3] Duke Univ, Sch Med, Dept Crit Care, Durham, NC USA
[4] Duke Univ, Sch Med, Dept Surg, Durham, NC USA
[5] Mayo Clin, Div Allergy Asthma & Clin Immunol, Scottsdale, AZ 85259 USA
关键词
mediators; MRGPRX2; pathophysiology; perioperative anaphylaxis; PLATELET-ACTIVATING-FACTOR; TRYPTASE LEVELS; CONTACT SYSTEM; HISTAMINE; RELEASE; ASSOCIATION; BIOMARKERS; RECEPTORS; MEDIATORS; ENOS;
D O I
10.1097/ACI.0000000000000994
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of reviewPerioperative anaphylaxis has historically been attributed to IgE/Fc epsilon RI-mediated reactions; there is now recognition of allergic and nonallergic triggers encompassing various reactions beyond IgE-mediated responses. This review aims to present recent advancements in knowledge regarding the mechanisms and pathophysiology of perioperative anaphylaxis.Recent findingsEmerging evidence highlights the role of the mast-cell related G-coupled protein receptor X2 pathway in direct mast cell degranulation, shedding light on previously unknown mechanisms. This pathway, alongside traditional IgE/Fc epsilon RI-mediated reactions, contributes to the complex nature of anaphylactic reactions. Investigations into the microbiota-anaphylaxis connection are ongoing, with potential implications for future treatment strategies. While serum tryptase levels serve as mast cell activation indicators, identifying triggers remains challenging. A range of mediators have been associated with anaphylaxis, including vasoactive peptides, proteases, lipid molecules, cytokines, chemokines, interleukins, complement components, and coagulation factors.SummaryFurther understanding of clinical endotypes and the microenvironment where anaphylactic reactions unfold is essential for standardizing mediator testing and characterization in perioperative anaphylaxis. Ongoing research aims to elucidate the mechanisms, pathways, and mediators involved across multiple organ systems, including the cardiovascular, respiratory, and integumentary systems, which will be crucial for improving patient outcomes.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 50 条
  • [31] PERIOPERATIVE ANAPHYLAXIS: EPIDEMIOLOGY
    Caimmi, S.
    Caimmi, D.
    Bernardini, R.
    Caffarelli, C.
    Crisafulli, G.
    Pingitore, G.
    Marseglia, G. L.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2011, 24 : 21 - 26
  • [32] Doxorubicin Cardiotoxicity: Pathophysiology Updates
    Christopher W. Hoeger
    Cole Turissini
    Aarti Asnani
    Current Treatment Options in Cardiovascular Medicine, 2020, 22
  • [33] Doxorubicin Cardiotoxicity: Pathophysiology Updates
    Hoeger, Christopher W.
    Turissini, Cole
    Asnani, Aarti
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2020, 22 (11)
  • [34] Anaphylaxis and anaphylactoid reactionsClassification and pathophysiology
    Johannes Ring
    Heidrun Behrendt
    Clinical Reviews in Allergy & Immunology, 1999, 17 : 387 - 399
  • [35] Pathophysiology of perioperative anaemia
    Singh, Sumit
    Gudzenko, Vadim
    Fink, Mitchell P.
    BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2012, 26 (04) : 431 - 439
  • [36] Getting in Shape: Updates in Exercise Anaphylaxis
    Carlisle, Annette
    Lieberman, Jay Adam
    CURRENT ALLERGY AND ASTHMA REPORTS, 2024, 24 (11) : 631 - 638
  • [37] Perioperative Anaphylaxis: Evaluation and Management
    Deepti Vellaichamy Manian
    Gerald W Volcheck
    Clinical Reviews in Allergy & Immunology, 2022, 62 : 383 - 399
  • [38] Perioperative anaphylaxis with no identifiable cause
    Horiuchi, Tatsuo
    Takazawa, Tomonori
    JA CLINICAL REPORTS, 2024, 10 (01)
  • [39] Perioperative anaphylaxis with no identifiable cause
    Tatsuo Horiuchi
    Tomonori Takazawa
    JA Clinical Reports, 10
  • [40] Perioperative Anaphylaxis in Pediatric Patients
    Salomone, John
    Monroy, Jennifer
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB83 - AB83